Benzofuran
- Product NameBenzofuran
- CAS271-89-6
- CBNumberCB8853413
- MFC8H6O
- MW118.14
- EINECS205-982-6
- MDL NumberMFCD00005847
- MOL File271-89-6.mol
- MSDS FileSDS
Chemical Properties
| Melting point | <-18℃ |
| Boiling point | 173-175 °C(lit.) |
| Density | 1.095 g/mL at 20 °C(lit.) |
| refractive index | n |
| Flash point | 133 °F |
| storage temp. | 2-8°C |
| solubility | soluble in Dichloromethane |
| pka | 33.2 |
| form | Crystalline Powder or Crystals |
| color | Yellow to green to yellow-brown |
| Water Solubility | insoluble |
| Merck | 14,1088 |
| BRN | 107704 |
| Henry's Law Constant | 1.9×10-2 mol/(m3Pa) at 25℃, HSDB (2015) |
| Major Application | cleaning products cosmetics flavors and fragrances food and beverages personal care |
| InChI | 1S/C8H6O/c1-2-4-8-7(3-1)5-6-9-8/h1-6H |
| InChIKey | IANQTJSKSUMEQM-UHFFFAOYSA-N |
| SMILES | c1ccc2occc2c1 |
Safety
| Symbol(GHS) |
 
|
|||||||||
| Signal word | Warning | |||||||||
| Hazard statements | H226-H351 | |||||||||
| Precautionary statements | P201-P210-P308+P313 | |||||||||
| Hazard Codes | Xn,Xi | |||||||||
| Risk Statements | 40-52-10 | |||||||||
| Safety Statements | 36/37-16 | |||||||||
| RIDADR | UN 1993 3/PG 3 | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | DF6423800 | |||||||||
| F | 10-23 | |||||||||
| Hazard Note | Irritant | |||||||||
| TSCA | TSCA listed | |||||||||
| HazardClass | 3 | |||||||||
| PackingGroup | III | |||||||||
| HS Code | 29329900 | |||||||||
| Storage Class | 3 - Flammable liquids | |||||||||
| Hazard Classifications | Carc. 2 Flam. Liq. 3 | |||||||||
| Hazardous Substances Data | 271-89-6(Hazardous Substances Data) | |||||||||
| Toxicity | Isolated from coal oil and used in the manufacture of coumarone-indene resin. This resin is used in paints, glue, etc. and is allowed in food packaging. Little is known about the toxicity of benzofuran to humans but acute toxicity in experimental animals involves liver and kidney failure. Chronic toxicity to animals involves damage to the liver, kidneys, lungs, and stomach. Lifetime administration (oral administration) caused cancer in both rats and mice. | |||||||||
| NFPA 704: |
|
